MedPath
NMPA Approval

Recombinant Human Interferon Beta 1a Solution for Injection

S20130072

October 8, 2019

S20130072

Drug Information

重组人干扰素β1a注射液

利比

注射剂

6.0×10^6IU/0.5ml/支(22μg)

生物制品

October 8, 2019

October 7, 2024

Company Information

Applicant Company

Merck Europe BV

Gustav Mahlerplein 102,1082 MA Amsterdam, The Netherlands

Manufacturing Company

merck serono s.p.a.

Via delle Magnolie 15, Zona Industriale di Modugno, 70026 Modugno(BA) Italy

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

重组人干扰素β1a注射液 - NMPA 批准文号 | MedPath